Te Li Chen
Vorstandsvorsitzender bei BIOGEND THERAPEUTICS CO., LTD.
Profil
Te Li Chen is currently the Chairman & General Manager at BioGend Therapeutics Co., Ltd.
and a Non-Executive Director at Jacobio Pharmaceuticals Group Co., Ltd.
He previously served as the Chairman at Mycenax Biotech, Inc. and as a Director at TPG Biologics, Inc. Prior to that, he was an Associate Professor at National Yang Ming University from 2006 to 2016.
Dr. Chen holds an undergraduate degree from National Defense Medical Center, conferred in 1995, and a doctorate degree from National Yang Ming University, conferred in 2008.
Aktive Positionen von Te Li Chen
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOGEND THERAPEUTICS CO., LTD. | Vorstandsvorsitzender | 07.07.2016 |
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Direktor/Vorstandsmitglied | 20.08.2020 |
Ehemalige bekannte Positionen von Te Li Chen
| Unternehmen | Position | Ende |
|---|---|---|
| National Yang Ming University | Corporate Officer/Principal | 01.01.2016 |
| TPG BIOLOGICS INC | Direktor/Vorstandsmitglied | - |
| MYCENAX BIOTECH INC. | Vorsitzender | - |
Ausbildung von Te Li Chen
| National Yang Ming University | Doctorate Degree |
| National Defense Medical Center | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| MYCENAX BIOTECH INC. | Health Technology |
| BIOGEND THERAPEUTICS CO., LTD. | Commercial Services |
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
TPG Biologics, Inc.
 TPG Biologics, Inc. Pharmaceuticals: MajorHealth Technology TPG Biologics, Inc. engages in the development of biopharmaceutical products. It offers antibody and protein drug design, cell line generation, process development, monoclonal antibody cell line similar drug products, and biological production for feasibility tests and animal studies. The company was founded on December 31, 2003 and headquartered in Taipei, Taiwan. | Health Technology |
